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Intestinal Ischemia-Reperfusion–Induced
Inflammation in Humans
Intestinal ischemia-reperfusion (I/R), the restriction and re-
turn of the blood supply, of the intestine is a common
pathological side effect of surgery that leads to intestinal
barrier loss and systemic inflammation. Although intestinal
I/R has been frequently studied in animal models, little is
known about the inflammatory sequelae of intestinal I/R in
humans. Using a human intestinal I/R model, Grootjans et al
(Am J Pathol 2010, 176:2283–2291) demonstrated that in-
testinal ischemia in humans results in intracellular leakage.
In addition, I/R-damaged intestinal tissue induced comple-
ment activation and increased production of inflammatory
cytokines as well as increased expression of intracellular
adhesion molecule 1, which led to a heightened neutrophil
influx. These data provide the basis for the development of
future preventative and therapeutic strategies to treat I/R.
Caveolin-1 Modulation of Endothelial Nitric
Oxide Synthase Activity Regulates Innate
Immunity and Sepsis-Induced Lung Injury
Nitric oxide plays a key role in innate immunity and inflam-
mation, as does caveolin-1, a scaffolding protein found in
caveolae. The caveolin-1/endothelial nitric oxide synthase
(eNOS) interaction is thought to be involved in this process.
To determine the respective roles of caveolin-1 and eNOS
in innate immunity and inflammation, Mirza et al (Am J
Pathol 2010, 176:2344–2351) generated mice that were
deficient in both CAV1 and NOS3. They show that eNOS
activation has an immunomodulatory effect in caveolin-
1–deficient mice, resulting in a decrease in the levels of
proinflammatory cytokines and improved survival when
compared with mice deficient in both caveolin-1 and
eNOS. In addition, eNOS activation in caveolin-1–defi-
cient mice protected against lipopolysaccharide-induced
lung injury. The interaction between caveolin-1 and eNOS
may therefore represent a new therapeutic target for
inflammation and lung injury.
Isolated Lymphoid Follicle Development in the
Intestine
Isolated lymphoid follicles (ILFs), which can serve as sites
for T cell-dependent and -independent IgA production, are
instrumental in the intestinal immune response against lu-
minal pathogens. Indeed, in a reversible process, environ-
mental stimuli from luminal microbiota induce nascent lym-
phoid cryptopatches to develop into the more mature ILFs.
McDonald et al (Am J Pathol 2010, 176:2367–2377) discov-
ered that intestinal microbiota recruited clusters of dendritic
cells to ILFs. Moreover, depletion of dendritic cells resulted
in regression of ILFs to reform cryptopatches, and ILF dif-
ferentiation was dependent on the chemokine CXCL13,
which is expressed by ILF dendritic cells. Taken together,
these data indicate that dendritic cell recruitment plays a
key role in ILF development and function, perhaps through
the secretion of CXCL13.
Tumor Exosomes Accelerate Tumor
Metastasis via MyD88
Microvessels, or exosomes, secreted from tumor cells can
stimulate inflammation, resulting in the expansion of my-
eloid-derived suppressor cells (MDSCs) and subsequent
tumor growth and metastasis. To determine the mecha-
nisms governing this response, Liu et al (Am J Pathol 2010,
176:2490–2499) investigated the role of MyD88, an adaptor
protein involved in Toll-like receptor signaling, in the im-
mune response to tumor exosomes. They found that MDSC
recruitment and expansion was inhibited in mice pretreated
with MyD88-deficient tumor exosomes and that wild-type
tumor exosomes caused higher levels of inflammatory cy-
tokine secretion than MyD88-deficient exosomes. Further-
more, lungs of MyD88-deficient mice expressed lower lev-
els of CCL2, a chemokine important in tumor metastasis,
than wild-type mice. MyD88 therefore plays a critical role in
tumor exosome-mediated MDSC expansion and tumor
metastasis.
MicroRNA Dysregulation May Contribute to
Melanoma Development
MicroRNAs (miRNAs) are a class of small noncoding RNAs
that regulate gene expression. To examine the hypothesis
that differential expression of miRNAs may contribute to
melanoma development, Chen et al (Am J Pathol 2010, 176:
2520–2529) compared levels of miRNA expression between
benign nevi and metastatic melanoma. Of the miRNAs ex-
amined, 31 were differentially expressed, with miR-193b
significantly down-regulated in all melanoma tissues exam-
ined. miR-193b overexpression in tumor cells inhibited pro-
liferation as well as down-regulated numerous genes, in-
cluding the cell cycle regulator cyclin D1 (CCND1). Indeed,
miR-193b directly repressed CCND1 by binding to the 3
untranslated region of CCND1 RNA. These results suggest
that miR-193b dysregulation may contribute to melanoma
development by altering cell proliferation.
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